CatalystTech/AI

SPACEX: CHEAPER BUT STILL NOT A BUY - MORE CAPEX PAINS AHEAD - SEEKINGALPHA

Capex pains and valuation concerns signal continued downside risk for SpaceX.

What changed

Capex pains and valuation concerns signal continued downside risk for SpaceX.

Why it matters

Capex pains and valuation concerns signal continued downside risk for SpaceX. — impact context not separately stored; see What changed.

Sources